Free Trial

Cipher Pharmaceuticals (CPH) Competitors

Cipher Pharmaceuticals logo
C$14.08 +0.56 (+4.14%)
As of 05/1/2025 04:00 PM Eastern

CPH vs. CRON, GUD, TLRY, ACB, WEED, FIRE, EPI, ICC, RIV, and LEAF

Should you be buying Cipher Pharmaceuticals stock or one of its competitors? The main competitors of Cipher Pharmaceuticals include Cronos Group (CRON), Knight Therapeutics (GUD), Tilray Brands (TLRY), Aurora Cannabis (ACB), Canopy Growth (WEED), Supreme Cannabis (FIRE), ESSA Pharma (EPI), ICC Labs (ICC), RIV Capital (RIV), and Leaf Mobile (LEAF). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Cipher Pharmaceuticals vs.

Cronos Group (TSE:CRON) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, community ranking, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

Cipher Pharmaceuticals has a net margin of 59.92% compared to Cronos Group's net margin of -42.65%. Cipher Pharmaceuticals' return on equity of 17.93% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-42.65% -4.40% -3.73%
Cipher Pharmaceuticals 59.92%17.93%7.90%

In the previous week, Cipher Pharmaceuticals had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Cipher Pharmaceuticals and 0 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.00 equaled Cipher Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Cronos Group Neutral
Cipher Pharmaceuticals Neutral

Cronos Group presently has a consensus price target of C$3.54, indicating a potential upside of 37.74%. Cipher Pharmaceuticals has a consensus price target of C$14.75, indicating a potential upside of 4.76%. Given Cronos Group's higher possible upside, research analysts clearly believe Cronos Group is more favorable than Cipher Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Cipher Pharmaceuticals
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75

Cipher Pharmaceuticals received 112 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 61.99% of users gave Cipher Pharmaceuticals an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

CompanyUnderperformOutperform
Cronos GroupOutperform Votes
69
50.74%
Underperform Votes
67
49.26%
Cipher PharmaceuticalsOutperform Votes
181
61.99%
Underperform Votes
111
38.01%

16.0% of Cronos Group shares are held by institutional investors. Comparatively, 1.4% of Cipher Pharmaceuticals shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Comparatively, 42.0% of Cipher Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Cipher Pharmaceuticals has lower revenue, but higher earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$76.86M8.83-C$32.78M-C$0.18-14.30
Cipher PharmaceuticalsC$19.03M13.28C$11.41MC$0.9115.55

Cronos Group has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Cipher Pharmaceuticals has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500.

Summary

Cipher Pharmaceuticals beats Cronos Group on 14 of the 18 factors compared between the two stocks.

Get Cipher Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CPH vs. The Competition

MetricCipher PharmaceuticalsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$252.78MC$2.17BC$5.54BC$5.66B
Dividend YieldN/A2.92%5.09%6.84%
P/E Ratio15.553.9522.6028.62
Price / Sales13.28505.10400.01601.02
Price / Cash3.5310.2538.1883.20
Price / Book3.556.606.773.71
Net IncomeC$11.41MC$20.70BC$3.22BC$301.04M
7 Day Performance13.55%0.74%1.10%0.03%
1 Month Performance11.30%1.55%2.48%-0.73%
1 Year Performance62.21%91.84%15.71%13.57%

Cipher Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CPH
Cipher Pharmaceuticals
0.6259 of 5 stars
C$14.08
+4.1%
C$14.75
+4.8%
+64.1%C$252.78MC$19.03M15.555Gap Up
CRON
Cronos Group
1.1561 of 5 stars
C$2.54
+1.6%
C$3.54
+39.4%
-31.5%C$670.72MC$76.86M-14.13450
GUD
Knight Therapeutics
1.4068 of 5 stars
C$5.92
+0.3%
C$7.48
+26.3%
+6.2%C$598.81MC$348.70M-19.76725
TLRY
Tilray Brands
N/AC$0.65
-5.8%
N/A-76.1%C$418.84MC$610.34M-1.572,650Positive News
ACB
Aurora Cannabis
1.6934 of 5 stars
C$6.47
-3.1%
C$8.75
+35.2%
-35.0%C$353.96MC$195.83M-7.991,073
WEED
Canopy Growth
1.356 of 5 stars
C$1.84
-5.6%
C$5.64
+206.4%
-87.7%C$296.00MC$519.68M-0.272,700
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533,684.0095.29N/AGap Up
RIV
RIV Capital
N/AN/AN/AN/AC$213.65MC$11.33M-1.6312
LEAF
Leaf Mobile
N/AN/AN/AN/AC$198.42MC$83.74M58.86150

Related Companies and Tools


This page (TSE:CPH) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners